Results 141 to 150 of about 2,210 (186)

A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus). [PDF]

Pituitary
Atila C, Winzeler B, Chifu I, Fassnacht M, Refardt J, Christ-Crain M.   +5 more
europepmc   +1 more source

Central and nephrogenic diabetes insipidus: updates on diagnosis and management. [PDF]

Front Endocrinol (Lausanne)
Flynn K, Hatfield J, Brown K, Vietor N, Hoang T.   +4 more
europepmc   +1 more source

The use of 1-desamino-8-D-arginine vasopressin (DDAVP) in the management of neurogenic diabetes insipidus (multiple etiologies in pediatric patients).

Minnesota medicine, 1979
D R, Brown, D L, Uden
openaire   +1 more source

Arginine Vasopressin Deficiency and Oxytocin Deficiency in the Endocrine Clinic.

J Clin Endocrinol Metab
Atila C, Refardt J, Christ-Crain M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Occurrence of diabetes mellitus in neurogenic diabetes insipidus

Acta Diabetologica, 1981
The occurrence of a family history of diabetes mellitus, of overt diabetes mellitus and of impaired glucose tolerance was investigated in a group of 43 patients with neurogenic diabetes insipidus. Family history was positive in 16.2% of these, similar to that in control subjects; manifest diabetes mellitus was present in 9.3%, impaired glucose ...
F Fallucca
exaly   +3 more sources

Neurogenic diabetes insipidus in children with hypoxic encephalopathy: Six new cases and a review of the literature

European Journal of Pediatrics, 1996
Hypoxic encephalopathy is rarely mentioned as a cause of neurogenic diabetes insipidus (DI) in children. We here report six cases of DI which occurred after severe hypoxic/ischaemic brain damage and include a review of the literature on 28 paediatric cases of neurogenic DI due solely to severe hypoxia/ischaemia.
Y J, Lee, F Y, Huang, E Y, Shen, H A, Kao, M Y, Ho, S D, Shyur, N C, Chiu   +6 more
exaly   +3 more sources

Neurogenic Diabetes Insipidus: Management with dDAVP (1-Desamino-8-D Arginine Vasopressin)

Annals of Internal Medicine, 1978
We used dDAVP, the 1-desamino-8-D arginine analogue of arginine vasopressin with high antidiuretic and low vasopressor potency, to treat 29 patients with neurogenic diabetes insipidus for up to 22 months. Intranasal dDAVP, 2.5 to 15 microgram twice daily, provided excellent control in most patients. Individual responses were independent of age, weight,
Seymour Reichlin
exaly   +3 more sources

Neurogenic diabetes insipidus

Pituitary, 2006
John A, Jane, Mary Lee, Vance, Edward R, Laws   +2 more
exaly   +3 more sources

Treatment of neurogenic diabetes insipidus

Annales d'Endocrinologie, 2011
Central or neurogenic diabetes insipidus results from a deficiency in antidiuretic hormone (ADH) or arginine-vasopressin (AVP). Treatment is based on replacement therapy with the hormone analog desmopressin (d-DAVP). d-DAVP can be administered subcutaneously to infants or patients with postoperative or posttraumatic brain injury being monitored for ...
Philippe, Chanson, Sylvie, Salenave
openaire   +2 more sources